Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.78 is in line with its 5-year average of 1.67, near the high end of its 5-year range (1.07–1.78).
As of the fiscal period ended Tuesday, June 30, 2026. 2.34% above its 12-month average of 1.74.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.78.
QUICK RATIO (ACID-TEST)
1.78
QUICK RATIO (ACID-TEST) AVG TTM
1.74
QUICK RATIO (ACID-TEST) AVG 3Y
1.67
QUICK RATIO (ACID-TEST) AVG 5Y
1.67
QUICK RATIO (ACID-TEST) AVG 10Y
1.57
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.34%
CURRENT VS 3Y AVG
+6.08%
CURRENT VS 5Y AVG
+6.17%
CURRENT VS 10Y AVG
+13.38%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-47.08%
vs the sector median at left
Surgery Partners, Inc.
Market Cap
$1.75B
Quick Ratio (Acid-Test)
1.78
TTM Avg
1.74
3Y Avg
1.67
5Y Avg
1.67
Market Cap
$1.74B
Quick Ratio (Acid-Test)
10.63
TTM Avg
5.62
3Y Avg
5.25
5Y Avg
6.00
Market Cap
$1.77B
Quick Ratio (Acid-Test)
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.02
TTM Avg
1.38
3Y Avg
1.55
5Y Avg
2.14
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
Market Cap
$1.73B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.71B
Quick Ratio (Acid-Test)
5.08
TTM Avg
6.50
3Y Avg
5.46
5Y Avg
6.20
Market Cap
$1.71B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | $1.75B | 1.78 | 1.74 | 1.67 | 1.67 |
| Novocure Ltd (NVCR)vs › | $1.74B | 2.70 | 2.06 | 4.13 | 5.41 |
| Absci Corporation (ABSI)vs › | $1.74B | 10.63 | 5.62 | 5.25 | 6.00 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | 8.30 | 3.78 | 3.78 | 3.78 |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | 1.02 | 1.38 | 1.55 | 2.14 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 1.70 | 1.79 | 1.95 | 2.14 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | 6.65 | 5.42 | 7.28 | 7.47 |
| Personalis, Inc. (PSNL)vs › | $1.71B | 5.08 | 6.50 | 5.46 | 6.20 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 1.07 | 0.89 | 0.95 | 0.97 |
| Xencor, Inc. (XNCR)vs › | $1.81B | 6.39 | 6.43 | 7.70 | 7.01 |
Quick Ratio
1.78
Excludes inventory
Current Ratio
1.95
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.78 |
| 2026-03-31 | 1.69 |
| 2025-12-31 | 1.71 |
| 2025-09-30 | 1.72 |
| 2025-06-30 | 1.78 |
| 2025-03-31 | 1.73 |
| 2024-12-31 | 1.65 |
| 2024-09-30 | 1.66 |
| 2024-06-30 | 1.69 |
| 2024-03-31 | 1.56 |
| 2023-12-31 | 1.57 |
| 2023-09-30 | 1.61 |
| 2023-06-30 | 1.61 |
| 2023-03-31 | 1.68 |
| 2022-12-31 | 1.72 |
| 2022-09-30 | 1.07 |
| 2022-06-30 | 1.39 |
| 2022-03-31 | 1.61 |
| 2021-12-31 | 1.65 |
| 2021-09-30 | 1.45 |
| 2021-06-30 | 1.68 |
| 2021-03-31 | 1.67 |
| 2020-12-31 | 1.34 |
| 2020-09-30 | 1.43 |
| 2020-06-30 | 1.22 |
| 2020-03-31 | 1.37 |
| 2019-12-31 | 1.20 |
| 2019-09-30 | 1.24 |
| 2019-06-30 | 1.32 |
| 2019-03-31 | 1.37 |
| 2018-12-31 | 1.56 |
| 2018-09-30 | 1.42 |
| 2018-06-30 | 1.44 |
| 2018-03-31 | 1.55 |
| 2017-12-31 | 1.71 |
| 2017-09-30 | 1.92 |
| 2017-06-30 | 1.73 |
| 2017-03-31 | 1.63 |
| 2016-12-31 | 1.78 |
| 2016-09-30 | 1.69 |
| 2016-06-30 | 1.60 |
| 2016-03-31 | 2.00 |
| 2015-12-31 | 1.57 |
| 2015-09-30 | 1.49 |
| 2015-06-30 | 1.50 |
| 2015-03-31 | 1.74 |
| 2014-12-31 | 1.73 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
